Herbal O O O O
medicines O O O O
have O O O O
been O O O O
used O O O O
to O O O O
treat O O O O
mental O O O O
health O O O O
disorders O O O O
since O O O O
ancient O O O O
times, O O O O
and O O O O
continue O O O O
to O O O O
be O O O O
useful O O O O
today. O O O O
SPECIAL O O O O
REPORT: O O O O
INTEGRATIVE O O O O
MEDICINE O O O O
Herbal O O O O
medicines O O O O
have O O O O
been O O O O
used O O O O
to O O O O
treat O O O O
mental O O O O
health O O O O
disorders O O O O
since O O O O
ancient O O O O
times. O O O O
Many O O O O
of O O O O
the O O O O
medications O O O O
used O O O O
in O O O O
contemporary O O O O
medicine O O O O
originated O O O O
from O O O O
plants—salicylic O O O O
acid O O O O
from O O O O
the O O O O
willow O O O O
tree, O O O O
for O O O O
example, O O O O
and O O O O
morphine O O O O
from O O O O
poppies. O O O O
Numerous O O O O
botanical O O O O
treatments O O O O
are O O O O
useful O O O O
in O O O O
general O O O O
psychiatry. O O O O
This O O O O
article O O O O
discusses O O O O
the O O O O
most O O O O
beneficial O O O O
and O O O O
commonly O O O O
used O O O O
herbal O O O O
medicines O O O O
to O O O O
treat O O O O
mental O O O O
health O O O O
concerns O O O O
([Table O O O O
1](https://cdn.sanity.io/images/0vv8moc6/psychtimes/1506d86938db66d7dba99a5ad4e83b16d6f9640d-1558x564.png/Lewis%20Table%201.png?w=1500&fit=max&auto=format)). O O O O
Americans O O O O
spent O O O O
$11.3 O O O O
billion O O O O
on O O O O
herbal O O O O
supplements O O O O
in O O O O
2020, O O O O
which O O O O
represented O O O O
a O O O O
record O O O O
increase O O O O
in O O O O
spending O O O O
of O O O O
17.3% O O O O
from O O O O
2019 O O O O
to O O O O
2020.1 O O O O
According O O O O
to O O O O
the O O O O
2020 O O O O
COVID-19 O O O O
consumer O O O O
survey O O O O
of O O O O
the O O O O
Council O O O O
for O O O O
Responsible O O O O
Nutrition,2 O O O O
among O O O O
those O O O O
who O O O O
increased O O O O
supplement O O O O
intake, O O O O
nearly O O O O
a O O O O
quarter O O O O
cited O O O O
mental O O O O
health-related O O O O
reasons, O O O O
including O O O O
stress O O O O
and O O O O
anxiety.3 O O O O
US O O O O
consumers O O O O
are O O O O
spending O O O O
the O O O O
most O O O O
money O O O O
on O O O O
the O O O O
following O O O O
herbs O O O O
with O O O O
mental O O O O
health O O O O
rhodiola. O O O O
Several O O O O
of O O O O
these O O O O
herbs O O O O
also O O O O
have O O O O
applications O O O O
for O O O O
physical O O O O
health, O O O O
such O O O O
as O O O O
inflammation, O O O O
cardiovascular O O O O
disease, O O O O
and O O O O
physical O O O O
performance. O O O O
The O O O O
research O O O O
evidence O O O O
and O O O O
consumer O O O O
spending O O O O
do O O O O
not O O O O
align. O O O O
As O O O O
psychiatrists, O O O O
we O O O O
can O O O O
help O O O O
guide O O O O
our O O O O
patients O O O O
in O O O O
making O O O O
beneficial O O O O
choices O O O O
when O O O O
they O O O O
choose O O O O
to O O O O
take O O O O
herbs. O O O O
Most O O O O
of O O O O
the O O O O
psychotropic O O O O
herbal O O O O
medicines O O O O
available O O O O
over O O O O
the O O O O
counter O O O O
are O O O O
quite O O O O
safe, O O O O
with O O O O
fewer O O O O
adverse O O O O
effects O O O O
than O O O O
conventional O O O O
antidepressants O O O O
or O O O O
antianxiety O O O O
agents.4 O O O O
Yet O O O O
not O O O O
all O O O O
are O O O O
safe. O O O O
For O O O O
example, O O O O
SJW O O O O
could O O O O
cause O O O O
a O O O O
switch O O O O
to O O O O
mania O O O O
in O O O O
bipolar O O O O
disorder5; O O O O
also, O O O O
it O O O O
should O O O O
not O O O O
be O O O O
taken O O O O
with O O O O
certain O O O O
other O O O O
drugs O O O O
due O O O O
to O O O O
potential O O O O
interactions.6 O O O O
Kava O O O O
supplements O O O O
made O O O O
from O O O O
the O O O O
incorrect O O O O
plant O O O O
type O O O O
and O O O O
incorrectly O O O O
processed O O O O
have O O O O
caused O O O O
liver O O O O
toxicity.7 O O O O
Thus, O O O O
it O O O O
is O O O O
important O O O O
to O O O O
know O O O O
which O O O O
herbal O O O O
agents O O O O
your O O O O
patient O O O O
may O O O O
be O O O O
taking O O O O
and O O O O
whether O O O O
herbal O O O O
medications O O O O
may O O O O
be O O O O
interacting O O O O
with O O O O
conventional O O O O
medications. O O O O
** O O O O
**Herbal Reason 5 O O
medicines Reason 5 O O
are Reason 5 O O
more Reason 5 O O
complex Reason 5 O O
than Reason 5 O O
conventional Reason 5 O O
medications, Reason 5 O O
which Reason 5 O O
may Reason 5 O O
discourage Reason 5 O O
psychiatrists Reason 5 O O
from Reason 5 O O
recommending Reason 5 O O
them. Reason 5 O O
Take Reason 5 O O
heart: Reason 5 O O
Most Reason 5 O O
herbs Reason 5 O O
are Reason 5 O O
quite Reason 5 O O
safe. Reason 5 O O
It Reason 5 O O
may Reason 5 O O
be Reason 5 O O
easiest Reason 5 O O
to Reason 5 O O
select Reason 5 O O
2 Reason 5 O O
or Reason 5 O O
3 Reason 5 O O
herbs, Reason 5 O O
to Reason 5 O O
start, Reason 5 O O
and Reason 5 O O
learn Reason 5 O O
about Reason 5 O O
them Reason 5 O O
in Reason 5 O O
depth. Reason 5 O O
Alternately, Reason 5 O O
choose Reason 5 O O
to Reason 5 O O
learn Reason 5 O O
about Reason 5 O O
the Reason 5 O O
herbs Reason 5 O O
your Reason 5 O O
patients Reason 5 O O
are Reason 5 O O
already Reason 5 O O
using Reason 5 O O
and Reason 5 O O
mixing Reason 5 O O
with Reason 5 O O
the Reason 5 O O
conventional Reason 5 O O
medications Reason 5 O O
we Reason 5 O O
may Reason 5 O O
be Reason 5 O O
prescribing. Reason 5 O O
Herbs' Reason 5 O O
complexity Reason 5 O O
comes Reason 5 O O
from Reason 5 O O
the Reason 5 O O
fact Reason 5 O O
that Reason 5 O O
they Reason 5 O O
are Reason 5 O O
whole Reason 5 O O
plants Reason 5 O O
rather Reason 5 O O
than Reason 5 O O
a Reason 5 O O
single Reason 5 O O
chemical Reason 5 O O
active Reason 5 O O
ingredient Reason 5 O O
in Reason 5 O O
a Reason 5 O O
medication. Reason 5 O O
A Reason 5 O O
plant's Reason 5 O O
beneficial Reason 5 O O
effect Reason 5 O O
may Reason 5 O O
be Reason 5 O O
related Reason 5 O O
to Reason 5 O O
complex Reason 5 O O
synergistic Reason 5 O O
and Reason 5 O O
polyvalent Reason 5 O O
interactions Reason 5 O O
among Reason 5 O O
many Reason 5 O O
of Reason 5 O O
its Reason 5 O O
own Reason 5 O O
components Reason 5 O O
or Reason 5 O O
multiple Reason 5 O O
plants. Reason 5 O O
A Reason 5 O O
plant Reason 5 O O
or Reason 5 O O
herbal Reason 5 O O
combination Reason 5 O O
may Reason 5 O O
contain Reason 5 O O
multiple Reason 5 O O
molecules Reason 5 O O
with Reason 5 O O
different Reason 5 O O
physiological Reason 5 O O
effects, Reason 5 O O
or Reason 5 O O
it Reason 5 O O
may Reason 5 O O
modify Reason 5 O O
the Reason 5 O O
absorption Reason 5 O O
or Reason 5 O O
metabolism Reason 5 O O
of Reason 5 O O
other Reason 5 O O
bioactive Reason 5 O O
components, Reason 5 O O
or Reason 5 O O
it Reason 5 O O
may Reason 5 O O
reduce Reason 5 O O
adverse Reason 5 O O
effects. Reason 5 O O
For Reason 5 O O
example, Reason 5 O O
adding Reason 5 O O
black Reason 5 O O
pepper Reason 5 O O
to Reason 5 O O
turmeric Reason 5 O O
may Reason 5 O O
dramatically Reason 5 O O
enhance Reason 5 O O
the Reason 5 O O
absorption Reason 5 O O
of Reason 5 O O
turmeric Reason 5 O O
into Reason 5 O O
the Reason 5 O O
bloodstream.8 Reason 5 O O
Within Reason 5 O O
a Reason 5 O O
single Reason 5 O O
plant, Reason 5 O O
valerian Reason 5 O O
has Reason 5 O O
several Reason 5 O O
different Reason 5 O O
effects Reason 5 O O
including Reason 5 O O
anxiolysis, Reason 5 O O
muscle Reason 5 O O
relaxation, Reason 5 O O
and Reason 5 O O
sleep Reason 5 O O
promotion; Reason 5 O O
notably, Reason 5 O O
valerian Reason 5 O O
involves Reason 5 O O
a Reason 5 O O
number Reason 5 O O
of Reason 5 O O
compounds Reason 5 O O
such Reason 5 O O
GABA; Reason 5 O O
benzodiazepine Reason 5 O O
receptor-binding Reason 5 O O
flavonoids; Reason 5 O O
terpenes, Reason 5 O O
which Reason 5 O O
inhibit Reason 5 O O
GABA Reason 5 O O
breakdown Reason 5 O O
smooth Reason 5 O O
muscle Reason 5 O O
relaxation; Reason 5 O O
and Reason 5 O O
lignans, Reason 5 O O
which Reason 5 O O
inhibit Reason 5 O O
serotonin Reason 5 O O
binding. Reason 5 O O
Herbal Reason 5 O O
medicines Reason 5 O O
may Reason 5 O O
work Reason 5 O O
better Reason 5 O O
because Reason 5 O O
of Reason 5 O O
the Reason 5 O O
complex Reason 5 O O
and Reason 5 O O
synergistic Reason 5 O O
interactions, Reason 5 O O
yet Reason 5 O O
that Reason 5 O O
strength Reason 5 O O
is Reason 5 O O
an Reason 5 O O
obstacle Reason 5 O O
to Reason 5 O O
standardized Reason 5 O O
research, Reason 5 O O
and Reason 5 O O
it Reason 5 O O
may Reason 5 O O
worry Reason 5 O O
clinicians. Reason 5 O O
Comparing Reason 5 O O
the Reason 5 O O
results Reason 5 O O
of Reason 5 O O
studies Reason 5 O O
on Reason 5 O O
different Reason 5 O O
preparations Reason 5 O O
of Reason 5 O O
the Reason 5 O O
same Reason 5 O O
herb Reason 5 O O
produced Reason 5 O O
by Reason 5 O O
different Reason 5 O O
manufacturers Reason 5 O O
may Reason 5 O O
be Reason 5 O O
difficult. Reason 5 O O
The Reason 5 O O
exact Reason 5 O O
chemical Reason 5 O O
composition Reason 5 O O
of Reason 5 O O
an Reason 5 O O
herbal Reason 5 O O
preparation Reason 5 O O
is Reason 5 O O
dependent Reason 5 O O
on Reason 5 O O
many Reason 5 O O
factors, Reason 5 O O
described Reason 5 O O
in Reason 5 O O
[Table Reason 5 O O
2](https://cdn.sanity.io/images/0vv8moc6/psychtimes/a96f80a59575702810b9213ddbc742a83fd00e18-472x296.png/Lewis%20Table%202.png?w=1500&fit=max&auto=format). Reason 5 O O
Research Reason 5 O O
on Reason 5 O O
herbal Reason 5 O O
medicines Reason 5 O O
is Reason 5 O O
elucidating Reason 5 O O
the Reason 5 O O
mental Reason 5 O O
health Reason 5 O O
effects Reason 5 O O
and Reason 5 O O
underlying Reason 5 O O
mechanisms Reason 5 O O
of Reason 5 O O
action Reason 5 O O
of Reason 5 O O
many Reason 5 O O
individual Reason 5 O O
herbs, Reason 5 O O
a Reason 5 O O
few Reason 5 O O
of Reason 5 O O
which Reason 5 O O
are Reason 5 O O
discussed Reason 5 O O
in Reason 5 O O
this Reason 5 O O
article. Reason 5 O O
Herbal Reason 5 O O
medicines Reason 5 O O
may Reason 5 O O
have Reason 5 O O
antidepressant, Reason 5 O O
anxiolytic, Reason 5 O O
sedative, Reason 5 O O
hypnotic, Reason 5 O O
analgesic, Reason 5 O O
and Reason 5 O O
cognitive-enhancing Reason 5 O O
effects, Reason 5 O O
in Reason 5 O O
addition Reason 5 O O
to Reason 5 O O
"adaptogenic" Reason 5 O O
effects, Reason 5 O O
that Reason 5 O O
increase Reason 5 O O
resilience Reason 5 O O
to Reason 5 O O
stress. Reason 5 O O
Key Reason 5 O O
mechanisms Reason 5 O O
of Reason 5 O O
actions Reason 5 O O
of Reason 5 O O
herbal Reason 5 O O
medicines Reason 5 O O
identified Reason 5 O O
in Reason 5 O O
research Reason 5 O O
can Reason 5 O O
be Reason 5 O O
found Reason 5 O O
in Reason 5 O O
[Table Reason 5 O O
3](https://cdn.sanity.io/images/0vv8moc6/psychtimes/1f1b12b0ccee5fdb6e2bf5fa0482b936c22729bf-472x610.png/Lewis%20Table%203.png). Reason 5 O O
** Reason 5 O O
**St. O O O O
John's O O O O
Wort O O O O
(Hypericum O O O O
perforatum) O O O O
The O O O O
use O O O O
of O O O O
SJW O O O O
dates O O O O
back O O O O
to O O O O
ancient O O O O
times, O O O O
and O O O O
it O O O O
is O O O O
among O O O O
the O O O O
most O O O O
researched O O O O
herbal O O O O
medicines O O O O
for O O O O
mental O O O O
health. O O O O
It O O O O
is O O O O
a O O O O
first-line O O O O
treatment O O O O
for O O O O
depression O O O O
in O O O O
several O O O O
European O O O O
countries. O O O O
Evidence: O O O O
A O O O O
2008 O O O O
Cochrane O O O O
meta-analysis9 O O O O
of O O O O
29 O O O O
trials O O O O
including O O O O
5489 O O O O
adult O O O O
patients O O O O
found O O O O
significant O O O O
results O O O O
from O O O O
18 O O O O
studies O O O O
in O O O O
favor O O O O
of O O O O
SJW O O O O
versus O O O O
placebo. O O O O
SJW O O O O
appeared O O O O
equivalent O O O O
to O O O O
selective O O O O
serotonin O O O O
reuptake O O O O
inhibitors O O O O
(SSRIs). O O O O
A O O O O
2016 O O O O
review10 O O O O
of O O O O
35 O O O O
studies O O O O
involving O O O O
nearly O O O O
7000 O O O O
adult O O O O
patients O O O O
found O O O O
that O O O O
SJW O O O O
monotherapy O O O O
for O O O O
mild-to-moderate O O O O
depression O O O O
was O O O O
superior O O O O
to O O O O
placebo O O O O
in O O O O
improving O O O O
depression O O O O
symptoms, O O O O
and O O O O
it O O O O
was O O O O
about O O O O
equivalent O O O O
in O O O O
effect O O O O
to O O O O
antidepressants. O O O O
In O O O O
research O O O O
studies, O O O O
the O O O O
dose O O O O
ranged O O O O
from O O O O
300 O O O O
mg O O O O
to O O O O
1800 O O O O
mg O O O O
per O O O O
day. O O O O
Most O O O O
preparations O O O O
used O O O O
in O O O O
research O O O O
contained O O O O
standardized O O O O
0.3% O O O O
hypericin O O O O
and O O O O
2% O O O O
to O O O O
5% O O O O
hyperforin. O O O O
Mechanism O O O O
inhibition O O O O
of O O O O
serotonin, O O O O
dopamine, O O O O
norepinephrine, O O O O
GABA, O O O O
and O O O O
L-glutamate O O O O
degradation O O O O
addition, O O O O
SJW O O O O
modulates O O O O
cortisol O O O O
levels. O O O O
Adverse O O O O
Effects: O O O O
SJW O O O O
appears O O O O
to O O O O
be O O O O
generally O O O O
well O O O O
tolerated, O O O O
with O O O O
adverse O O O O
effects O O O O
occurring O O O O
in O O O O
0.1% O O O O
to O O O O
5.7% O O O O
of O O O O
users O O O O
(comparable O O O O
with O O O O
placebo).11 O O O O
Most O O O O
common O O O O
adverse O O O O
reactions O O O O
involve O O O O
reversible O O O O
dermatological O O O O
and O O O O
gastrointestinal O O O O
issues. O O O O
Per O O O O
the O O O O
2016 O O O O
review O O O O
of O O O O
the O O O O
35 O O O O
studies O O O O
reviewed, O O O O
34 O O O O
included O O O O
safety O O O O
data, O O O O
and O O O O
overall O O O O
SWJ O O O O
did O O O O
not O O O O
cause O O O O
more O O O O
adverse O O O O
effects O O O O
than O O O O
placebo. O O O O
SJW O O O O
is O O O O
a O O O O
potent O O O O
inducer O O O O
of O O O O
CYP O O O O
3A4 O O O O
and O O O O
P O O O O
glycoprotein, O O O O
and O O O O
it O O O O
can O O O O
lower O O O O
the O O O O
levels O O O O
of O O O O
many O O O O
commonly O O O O
used O O O O
medications O O O O
including O O O O
oral O O O O
contraceptives, O O O O
methadone, O O O O
and O O O O
cyclosporine. O O O O
It O O O O
is O O O O
best O O O O
to O O O O
check O O O O
reference O O O O
materials O O O O
for O O O O
possible O O O O
SJW-medication O O O O
interactions O O O O
or O O O O
even O O O O
to O O O O
avoid O O O O
use O O O O
with O O O O
certain O O O O
medications. O O O O
Preparations O O O O
that O O O O
are O O O O
< O O O O
4 O O O O
mg O O O O
of O O O O
hyperforin O O O O
may O O O O
be O O O O
safer O O O O
and O O O O
less O O O O
likely O O O O
to O O O O
cause O O O O
drug-herb O O O O
interactions. O O O O
Rare, O O O O
serious O O O O
adverse O O O O
effects O O O O
include O O O O
serotonin O O O O
syndrome O O O O
(when O O O O
combined O O O O
with O O O O
an O O O O
SSRI), O O O O
induction O O O O
to O O O O
mania, O O O O
and O O O O
psychosis. O O O O
A O O O O
2004 O O O O
article O O O O
reported O O O O
17 O O O O
cases O O O O
in O O O O
the O O O O
literature O O O O
where O O O O
SJW O O O O
was O O O O
associated O O O O
with O O O O
likely O O O O
triggering O O O O
mania O O O O
or O O O O
psychosis.12 O O O O
Clinical O O O O
Pearls: O O O O
- O O O O
The O O O O
main O O O O
concern O O O O
about O O O O
and O O O O
obstacle O O O O
to O O O O
SJW O O O O
use O O O O
is O O O O
concern O O O O
for O O O O
drug O O O O
interactions. O O O O
- O O O O
In O O O O
clinical O O O O
practice, O O O O
you O O O O
may O O O O
find O O O O
better O O O O
adherence O O O O
to O O O O
SJW O O O O
if O O O O
you O O O O
recommend O O O O
a O O O O
specific O O O O
formulation O O O O
and O O O O
monitor O O O O
the O O O O
use O O O O
of O O O O
SJW O O O O
as O O O O
you O O O O
would O O O O
any O O O O
other O O O O
medication. O O O O
Increase O O O O
the O O O O
dose O O O O
gradually O O O O
from O O O O
300 O O O O
mg O O O O
up O O O O
to O O O O
a O O O O
maximum O O O O
1800 O O O O
mg. O O O O
Monitor O O O O
for O O O O
adverse O O O O
effects, O O O O
and O O O O
if O O O O
there O O O O
is O O O O
no O O O O
benefit O O O O
by O O O O
6 O O O O
weeks, O O O O
consider O O O O
adding O O O O
other O O O O
augmenting O O O O
agents O O O O
or O O O O
switching O O O O
to O O O O
a O O O O
different O O O O
agent. O O O O
** O O O O
**Turmeric Reason 3 O O
(Curcuma Reason 3 O O
longa) Reason 3 O O
Turmeric Reason 3 O O
is Reason 3 O O
a Reason 3 O O
common Reason 3 O O
cooking Reason 3 O O
spice Reason 3 O O
and Reason 3 O O
a Reason 3 O O
traditional Reason 3 O O
Ayurvedic Reason 3 O O
and Reason 3 O O
Chinese Reason 3 O O
medicine. Reason 3 O O
Evidence: Reason 3 O O
A Reason 3 O O
2020 Reason 3 O O
meta-analysis Reason 3 O O
of Reason 3 O O
10 Reason 3 O O
studies Reason 3 O O
involving Reason 3 O O
530 Reason 3 O O
participants Reason 3 O O
found Reason 3 O O
a Reason 3 O O
significant Reason 3 O O
and Reason 3 O O
large Reason 3 O O
effect Reason 3 O O
size Reason 3 O O
of Reason 3 O O
curcumin Reason 3 O O
for Reason 3 O O
depressive Reason 3 O O
symptoms Reason 3 O O
based Reason 3 O O
on Reason 3 O O
10 Reason 3 O O
studies Reason 3 O O
and Reason 3 O O
on Reason 3 O O
anxiety Reason 3 O O
symptoms Reason 3 O O
based Reason 3 O O
on Reason 3 O O
5 Reason 3 O O
studies.13 Reason 3 O O
Curcumin Reason 3 O O
was Reason 3 O O
well Reason 3 O O
tolerated. Reason 3 O O
A Reason 3 O O
meta-analysis14 Reason 3 O O
of Reason 3 O O
6 Reason 3 O O
trials Reason 3 O O
lasting Reason 3 O O
4 Reason 3 O O
to Reason 3 O O
8 Reason 3 O O
weeks Reason 3 O O
and Reason 3 O O
involving Reason 3 O O
377 Reason 3 O O
patients Reason 3 O O
with Reason 3 O O
depression Reason 3 O O
showed Reason 3 O O
turmeric's Reason 3 O O
significant Reason 3 O O
benefit Reason 3 O O
in Reason 3 O O
reducing Reason 3 O O
depressive Reason 3 O O
symptoms Reason 3 O O
compared Reason 3 O O
with Reason 3 O O
placebo. Reason 3 O O
Three Reason 3 O O
studies Reason 3 O O
also Reason 3 O O
reported Reason 3 O O
significant Reason 3 O O
antianxiety Reason 3 O O
effects. Reason 3 O O
** Reason 3 O O
**A O O O O
6-week O O O O
randomized O O O O
controlled O O O O
trial O O O O
(RCT) O O O O
of O O O O
108 O O O O
male O O O O
adults O O O O
in O O O O
China O O O O
showed O O O O
benefit O O O O
for O O O O
1000 O O O O
mg O O O O
curcumin O O O O
per O O O O
day O O O O
versus O O O O
placebo O O O O
as O O O O
an O O O O
augmentation O O O O
to O O O O
escitalopram.15 O O O O
In O O O O
addition, O O O O
the O O O O
study O O O O
documented O O O O
that O O O O
curcumin O O O O
decreased O O O O
inflammatory O O O O
cytokines O O O O
(interleukin-1 O O O O
beta O O O O
and O O O O
tumor O O O O
necrosis O O O O
factor O O O O
alpha) O O O O
and O O O O
salivary O O O O
cortisol, O O O O
and O O O O
increased O O O O
brain-derived O O O O
neurotrophic O O O O
factor. O O O O
Mechanism O O O O
of O O O O
turmeric, O O O O
has O O O O
anti-inflammatory, O O O O
and O O O O
monoamine O O O O
regulatory O O O O
effects. O O O O
Clinical O O O O
Pearls: O O O O
- O O O O
Turmeric O O O O
may O O O O
be O O O O
particularly O O O O
useful O O O O
for O O O O
patients O O O O
with O O O O
depression O O O O
and O O O O
inflammation. O O O O
When O O O O
checking O O O O
blood O O O O
work, O O O O
check O O O O
high-sensitivity O O O O
C-reactive O O O O
protein, O O O O
and O O O O
if O O O O
it O O O O
is O O O O
higher O O O O
than O O O O
1 O O O O
mg/L, O O O O
consider O O O O
adding O O O O
turmeric O O O O
to O O O O
an O O O O
antidepressant. O O O O
- O O O O
Recommend O O O O
formulations O O O O
that O O O O
are O O O O
of O O O O
high O O O O
quality O O O O
and O O O O
contain O O O O
black O O O O
pepper O O O O
extract O O O O
to O O O O
increase O O O O
absorption. O O O O
** O O O O
**Saffron Reason 3 O O
(Crocus Reason 3 O O
sativus) Reason 3 O O
The Reason 3 O O
majority Reason 3 O O
of Reason 3 O O
research Reason 3 O O
on Reason 3 O O
saffron Reason 3 O O
was Reason 3 O O
conducted Reason 3 O O
in Reason 3 O O
Iran, Reason 3 O O
where Reason 3 O O
it Reason 3 O O
has Reason 3 O O
been Reason 3 O O
used Reason 3 O O
as Reason 3 O O
a Reason 3 O O
traditional Reason 3 O O
treatment Reason 3 O O
for Reason 3 O O
mood Reason 3 O O
for Reason 3 O O
centuries. Reason 3 O O
Its Reason 3 O O
constituents Reason 3 O O
safranal Reason 3 O O
and Reason 3 O O
crocin Reason 3 O O
show Reason 3 O O
antidepressant, Reason 3 O O
anxiolytic, Reason 3 O O
and Reason 3 O O
hypnotic Reason 3 O O
effects. Reason 3 O O
Crocin Reason 3 O O
may Reason 3 O O
act Reason 3 O O
through Reason 3 O O
reuptake Reason 3 O O
inhibition Reason 3 O O
of Reason 3 O O
dopamine Reason 3 O O
and Reason 3 O O
norepinephrine, Reason 3 O O
and Reason 3 O O
safranal Reason 3 O O
via Reason 3 O O
** Reason 3 O O
**In O O O O
addition, O O O O
saffron O O O O
Evidence: O O O O
A O O O O
meta-analysis O O O O
of O O O O
5 O O O O
published O O O O
high-quality O O O O
RCTs O O O O
showed O O O O
a O O O O
large O O O O
effect O O O O
size O O O O
in O O O O
favor O O O O
of O O O O
saffron O O O O
versus O O O O
placebo O O O O
for O O O O
depressive O O O O
symptoms, O O O O
and O O O O
equal O O O O
effect O O O O
to O O O O
antidepressant O O O O
groups.16 O O O O
In O O O O
addition, O O O O
a O O O O
12-week O O O O
double-blind O O O O
RCT O O O O
(n O O O O
= O O O O
60) O O O O
of O O O O
50 O O O O
mg O O O O
per O O O O
day O O O O
of O O O O
saffron O O O O
was O O O O
positive.17 O O O O
However, O O O O
the O O O O
conducted O O O O
studies O O O O
were O O O O
small O O O O
and O O O O
of O O O O
short O O O O
duration, O O O O
and O O O O
little O O O O
research O O O O
has O O O O
been O O O O
conducted O O O O
at O O O O
Western O O O O
study O O O O
sites. O O O O
** O O O O
**Clinical Reason 3 O O
Pearls: Reason 3 O O
- Reason 3 O O
Look Reason 3 O O
for Reason 3 O O
a Reason 3 O O
higher Reason 3 O O
dose Reason 3 O O
of Reason 3 O O
saffron Reason 3 O O
when Reason 3 O O
selecting Reason 3 O O
a Reason 3 O O
supplement. Reason 3 O O
- Reason 3 O O
Consider Reason 3 O O
twice Reason 3 O O
a Reason 3 O O
day Reason 3 O O
dosing. Reason 3 O O
- Reason 3 O O
Saffron Reason 3 O O
can Reason 3 O O
be Reason 3 O O
used Reason 3 O O
as Reason 3 O O
monotherapy Reason 3 O O
or Reason 3 O O
adjunctive Reason 3 O O
use Reason 3 O O
for Reason 3 O O
mild Reason 3 O O
to Reason 3 O O
moderate Reason 3 O O
depression. Reason 3 O O
Lavender Reason 3 O O
(Lavandula Reason 3 O O
angustifolia) Reason 3 O O
Lavender Reason 3 O O
has Reason 3 O O
been Reason 3 O O
used Reason 3 O O
in Reason 3 O O
aromatherapy Reason 3 O O
for Reason 3 O O
anxiety. Reason 3 O O
Evidence: Reason 3 O O
A Reason 3 O O
2021 Reason 3 O O
meta-analysis Reason 3 O O
of Reason 3 O O
17 Reason 3 O O
articles Reason 3 O O
showed Reason 3 O O
significant Reason 3 O O
benefit Reason 3 O O
of Reason 3 O O
lavender Reason 3 O O
for Reason 3 O O
decreasing Reason 3 O O
depression Reason 3 O O
symptoms.18 Reason 3 O O
Nearly Reason 3 O O
three-fourths Reason 3 O O
of Reason 3 O O
the Reason 3 O O
studies Reason 3 O O
in Reason 3 O O
this Reason 3 O O
meta-analysis Reason 3 O O
were Reason 3 O O
conducted Reason 3 O O
in Reason 3 O O
Iran, Reason 3 O O
most Reason 3 O O
studies Reason 3 O O
involved Reason 3 O O
aromatherapy, Reason 3 O O
and Reason 3 O O
5 Reason 3 O O
studies Reason 3 O O
involved Reason 3 O O
ingesting Reason 3 O O
lavender. Reason 3 O O
One Reason 3 O O
study Reason 3 O O
evaluated Reason 3 O O
the Reason 3 O O
effects Reason 3 O O
of Reason 3 O O
lavender Reason 3 O O
essential Reason 3 O O
oil Reason 3 O O
(Silexan) Reason 3 O O
on Reason 3 O O
patients Reason 3 O O
with Reason 3 O O
mixed Reason 3 O O
anxiety Reason 3 O O
and Reason 3 O O
depressive Reason 3 O O
disorder, Reason 3 O O
a Reason 3 O O
condition Reason 3 O O
with Reason 3 O O
subsyndromal Reason 3 O O
symptoms Reason 3 O O
of Reason 3 O O
anxiety Reason 3 O O
and Reason 3 O O
depression.19 Reason 3 O O
In Reason 3 O O
this Reason 3 O O
study, Reason 3 O O
318 Reason 3 O O
patients Reason 3 O O
received Reason 3 O O
80 Reason 3 O O
mg Reason 3 O O
Silexan Reason 3 O O
or Reason 3 O O
placebo Reason 3 O O
for Reason 3 O O
70 Reason 3 O O
days. Reason 3 O O
** Reason 3 O O
**Silexan O O O O
was O O O O
beneficial O O O O
for O O O O
decreasing O O O O
depression O O O O
scores O O O O
and O O O O
improving O O O O
quality O O O O
of O O O O
life. O O O O
The O O O O
main O O O O
adverse O O O O
effect O O O O
was O O O O
eructation. O O O O
Clinical O O O O
Pearls: O O O O
- O O O O
Select O O O O
supplements O O O O
with O O O O
80 O O O O
mg O O O O
to O O O O
160 O O O O
mg O O O O
of O O O O
lavender O O O O
essential O O O O
oil O O O O
per O O O O
day O O O O
in O O O O
the O O O O
form O O O O
of O O O O
soft O O O O
gels. O O O O
- O O O O
Weak O O O O
evidence O O O O
for O O O O
monotherapy, O O O O
more O O O O
appropriate O O O O
for O O O O
adjunctive O O O O
use O O O O
in O O O O
major O O O O
depressive O O O O
disorder O O O O
and O O O O
generalized O O O O
anxiety O O O O
disorder. O O O O
** O O O O
**Cannabis Reason 2 O O
(Cannabis Reason 2 O O
sativa) Reason 2 O O
Another Reason 2 O O
interesting Reason 2 O O
herb Reason 2 O O
is Reason 2 O O
the Reason 2 O O
sativa), Reason 2 O O
which Reason 2 O O
contains Reason 2 O O
delta-9-tetrahydrocannabinol Reason 2 O O
(THC) Reason 2 O O
and Reason 2 O O
CBD. Reason 2 O O
Currently, Reason 2 O O
despite Reason 2 O O
the Reason 2 O O
very Reason 2 O O
high Reason 2 O O
spending Reason 2 O O
on Reason 2 O O
these Reason 2 O O
by Reason 2 O O
consumers, Reason 2 O O
very Reason 2 O O
little Reason 2 O O
research Reason 2 O O
is Reason 2 O O
available Reason 2 O O
to Reason 2 O O
guide Reason 2 O O
use. Reason 2 O O
** Reason 2 O O
**A O O O O
review O O O O
article O O O O
published O O O O
in O O O O
Lancet O O O O
Psychiatry O O O O
in O O O O
2019 O O O O
of O O O O
83 O O O O
studies, O O O O
including O O O O
40 O O O O
RCTs O O O O
and O O O O
3067 O O O O
participants, O O O O
concluded O O O O
that O O O O
there O O O O
is O O O O
a O O O O
lack O O O O
of O O O O
evidence O O O O
that O O O O
cannabinoids O O O O
improve O O O O
symptoms O O O O
of O O O O
depression, O O O O
anxiety, O O O O
attention-deficit/hyperactivity O O O O
disorder, O O O O
tics, O O O O
posttraumatic O O O O
stress O O O O
disorder O O O O
(PTSD), O O O O
or O O O O
psychosis.20 O O O O
The O O O O
single O O O O
positive O O O O
finding O O O O
was O O O O
that O O O O
there O O O O
was O O O O
very-low-quality O O O O
evidence O O O O
that O O O O
THC O O O O
with O O O O
or O O O O
without O O O O
CBD O O O O
may O O O O
help O O O O
with O O O O
anxiety O O O O
for O O O O
those O O O O
who O O O O
also O O O O
have O O O O
other O O O O
medical O O O O
conditions. O O O O
A O O O O
2021 O O O O
review O O O O
noted O O O O
that O O O O
with O O O O
only O O O O
8 O O O O
very O O O O
small O O O O
studies O O O O
at O O O O
the O O O O
time, O O O O
there O O O O
was O O O O
insufficient O O O O
evidence O O O O
for O O O O
clinicians O O O O
recommending O O O O
CBD O O O O
or O O O O
THC O O O O
to O O O O
manage O O O O
mood O O O O
disorders, O O O O
anxiety, O O O O
or O O O O
PTSD.21 O O O O
Clinically, O O O O
many O O O O
psychiatrists O O O O
recommend O O O O
CBD O O O O
for O O O O
anxiety O O O O
and O O O O
warn O O O O
about O O O O
the O O O O
dangers O O O O
of O O O O
chronic O O O O
THC O O O O
use—yet, O O O O
at O O O O
this O O O O
time, O O O O
we O O O O
do O O O O
not O O O O
have O O O O
much O O O O
research O O O O
evidence O O O O
to O O O O
guide O O O O
us. O O O O
In O O O O
my O O O O
clinical O O O O
practice, O O O O
I O O O O
find O O O O
that O O O O
some O O O O
patients O O O O
find O O O O
CBD O O O O
without O O O O
THC O O O O
or O O O O
with O O O O
a O O O O
minimal O O O O
amount O O O O
of O O O O
THC O O O O
(20:1 O O O O
ratio O O O O
of O O O O
CBD O O O O
to O O O O
THC) O O O O
useful O O O O
for O O O O
anxiety, O O O O
sleep, O O O O
and O O O O
inflammation O O O O
without O O O O
significant O O O O
adverse O O O O
effects. O O O O
The O O O O
dose O O O O
range O O O O
of O O O O
CBD O O O O
is O O O O
large, O O O O
from O O O O
approximately O O O O
5 O O O O
mg O O O O
to O O O O
45 O O O O
mg O O O O
for O O O O
effect. O O O O
Many O O O O
patients O O O O
prefer O O O O
CBD O O O O
in O O O O
capsules O O O O
for O O O O
consistency O O O O
of O O O O
dose. O O O O
Clinical O O O O
Pearls: O O O O
- O O O O
Soft O O O O
gel O O O O
formulations O O O O
of O O O O
CBD O O O O
at O O O O
15mg O O O O
are O O O O
good O O O O
place O O O O
to O O O O
start O O O O
and O O O O
recommend O O O O
to O O O O
patients O O O O
to O O O O
start O O O O
with O O O O
one O O O O
soft O O O O
gel, O O O O
if O O O O
not O O O O
effect O O O O
take O O O O
another O O O O
one O O O O
30 O O O O
min O O O O
later, O O O O
and O O O O
another O O O O
one O O O O
30 O O O O
min O O O O
later O O O O
to O O O O
determine O O O O
the O O O O
effective O O O O
dose. O O O O
- O O O O
Avoid O O O O
confusion O O O O
with O O O O
hemp O O O O
seed O O O O
oil, O O O O
which O O O O
does O O O O
not O O O O
contain O O O O
CBD.** O O O O
**Other Reason 5 O O
promising Reason 5 O O
herbs Reason 5 O O
for Reason 5 O O
the Reason 5 O O
treatment Reason 5 O O
of Reason 5 O O
mental Reason 5 O O
health Reason 5 O O
disorders Reason 5 O O
include Reason 5 O O
ashwagandha Reason 5 O O
with Reason 5 O O
moderate Reason 5 O O
evidence Reason 5 O O
and Reason 5 O O
galphimia Reason 5 O O
with Reason 5 O O
modest Reason 5 O O
evidence Reason 5 O O
for Reason 5 O O
anxiety Reason 5 O O
disorders. Reason 5 O O
Gingko Reason 5 O O
has Reason 5 O O
week Reason 5 O O
support Reason 5 O O
for Reason 5 O O
adjunctive Reason 5 O O
treatment Reason 5 O O
of Reason 5 O O
negative Reason 5 O O
symptoms Reason 5 O O
in Reason 5 O O
schizophrenia.22 Reason 5 O O
Concluding Reason 5 O O
Thoughts Reason 5 O O
Herbal Reason 5 O O
medicine Reason 5 O O
is Reason 5 O O
an Reason 5 O O
important Reason 5 O O
addition Reason 5 O O
to Reason 5 O O
our Reason 5 O O
conventional Reason 5 O O
medication Reason 5 O O
toolbox. Reason 5 O O
Herbs Reason 5 O O
are Reason 5 O O
generally Reason 5 O O
well Reason 5 O O
tolerated Reason 5 O O
and Reason 5 O O
affordable. Reason 5 O O
For Reason 5 O O
patients Reason 5 O O
interested Reason 5 O O
in Reason 5 O O
using Reason 5 O O
herbs, Reason 5 O O
we Reason 5 O O
have Reason 5 O O
sufficient Reason 5 O O
evidence Reason 5 O O
to Reason 5 O O
recommend Reason 5 O O
several Reason 5 O O
agents Reason 5 O O
discussed Reason 5 O O
in Reason 5 O O
this Reason 5 O O
article. Reason 5 O O
It Reason 5 O O
is Reason 5 O O
important Reason 5 O O
to Reason 5 O O
ask Reason 5 O O
patients Reason 5 O O
what Reason 5 O O
herbs Reason 5 O O
and Reason 5 O O
supplements Reason 5 O O
they Reason 5 O O
take Reason 5 O O
and Reason 5 O O
to Reason 5 O O
assess Reason 5 O O
for Reason 5 O O
potential Reason 5 O O
drug-herb Reason 5 O O
interactions Reason 5 O O
and Reason 5 O O
adverse Reason 5 O O
effects. Reason 5 O O
Dr Reason 5 O O
Lewis Reason 5 O O
is Reason 5 O O
a Reason 5 O O
psychiatrist Reason 5 O O
and Reason 5 O O
psychotherapist Reason 5 O O
at Reason 5 O O
Mind Reason 5 O O
Body Reason 5 O O
Seven Reason 5 O O
Psychiatry, Reason 5 O O
and Reason 5 O O
a Reason 5 O O
clinical Reason 5 O O
assistant Reason 5 O O
professor Reason 5 O O
at Reason 5 O O
New Reason 5 O O
York Reason 5 O O
University. Reason 5 O O
References Reason 5 O O
1. Reason 5 O O
Smith Reason 5 O O
T, Reason 5 O O
Majid Reason 5 O O
F, Reason 5 O O
Eckl Reason 5 O O
V, Reason 5 O O
Reynolds Reason 5 O O
CM. Reason 5 O O
Herbal Reason 5 O O
supplement Reason 5 O O
sales Reason 5 O O
in Reason 5 O O
US Reason 5 O O
increase Reason 5 O O
by Reason 5 O O
record-breaking Reason 5 O O
17.3% Reason 5 O O
in Reason 5 O O
2020. Reason 5 O O
HerbalEGram. Reason 5 O O
2021;131:52-65. Reason 5 O O
2. Reason 5 O O
Smith Reason 5 O O
T. Reason 5 O O
CRN Reason 5 O O
consumer Reason 5 O O
surveys Reason 5 O O
find Reason 5 O O
changes Reason 5 O O
in Reason 5 O O
supplement Reason 5 O O
use Reason 5 O O
in Reason 5 O O
2020. Reason 5 O O
American Reason 5 O O
Botanical Reason 5 O O
Council/Herbal Reason 5 O O
Medicine Reason 5 O O
Institute. Reason 5 O O
December Reason 5 O O
2020. Reason 5 O O
Accessed Reason 5 O O
August Reason 5 O O
31, Reason 5 O O
2022. Reason 5 O O
[https://www.herbalgram.org/resources/herbalegram/volumes/volume-17/number-12-december-2020/crn-supplement-survey/crn-supplement-survey/](https://www.herbalgram.org/resources/herbalegram/volumes/volume-17/number-12-december-2020/crn-supplement-survey/crn-supplement-survey/) Reason 5 O O
3. Reason 5 O O
CRN's Reason 5 O O
COVID-19 Reason 5 O O
survey Reason 5 O O
on Reason 5 O O
dietary Reason 5 O O
supplements: Reason 5 O O
consumer Reason 5 O O
insights Reason 5 O O
on Reason 5 O O
usage Reason 5 O O
and Reason 5 O O
attitudes Reason 5 O O
about Reason 5 O O
dietary Reason 5 O O
supplements Reason 5 O O
in Reason 5 O O
light Reason 5 O O
of Reason 5 O O
the Reason 5 O O
coronavirus Reason 5 O O
pandemic. Reason 5 O O
Council Reason 5 O O
for Reason 5 O O
Responsible Reason 5 O O
Nutrition. Reason 5 O O
Accessed Reason 5 O O
August Reason 5 O O
31, Reason 5 O O
2022. Reason 5 O O
[https://www.crnusa.org/COVID19survey](https://www.crnusa.org/COVID19survey) Reason 5 O O
4. Reason 5 O O
Sarris Reason 5 O O
J, Reason 5 O O
Panossian Reason 5 O O
A, Reason 5 O O
Schweitzer Reason 5 O O
I, Reason 5 O O
et Reason 5 O O
al. Reason 5 O O
Herbal Reason 5 O O
medicine Reason 5 O O
for Reason 5 O O
depression, Reason 5 O O
anxiety Reason 5 O O
and Reason 5 O O
insomnia: Reason 5 O O
a Reason 5 O O
review Reason 5 O O
of Reason 5 O O
psychopharmacology Reason 5 O O
and Reason 5 O O
clinical Reason 5 O O
evidence. Reason 5 O O
Eur Reason 5 O O
Neuropsychopharmacol. Reason 5 O O
2011;21(12):841-860. Reason 5 O O
5. Reason 5 O O
Fahmi Reason 5 O O
M, Reason 5 O O
Huang Reason 5 O O
C, Reason 5 O O
Schweitzer Reason 5 O O
I. Reason 5 O O
A Reason 5 O O
case Reason 5 O O
of Reason 5 O O
mania Reason 5 O O
induced Reason 5 O O
by Reason 5 O O
hypericum. Reason 5 O O
World Reason 5 O O
J Reason 5 O O
Biol Reason 5 O O
Psychiatry. Reason 5 O O
2002;3(1):58-59. Reason 5 O O
6. Reason 5 O O
Madabushi Reason 5 O O
R, Reason 5 O O
Frank Reason 5 O O
B, Reason 5 O O
Drewelow Reason 5 O O
B, Reason 5 O O
et Reason 5 O O
al. Reason 5 O O
Hyperforin Reason 5 O O
in Reason 5 O O
St. Reason 5 O O
John's Reason 5 O O
wort Reason 5 O O
drug Reason 5 O O
clinical Reason 5 O O
AAPS Reason 5 O O
J. Reason 5 O O
2013;15(1):195-218. Reason 5 O O
9. Reason 5 O O
Linde Reason 5 O O
K, Reason 5 O O
Berner Reason 5 O O
Apaydin Reason 5 O O
EA, Reason 5 O O
Maher Reason 5 O O
AR, Reason 5 O O
Shanman Reason 5 O O
R, Reason 5 O O
et Reason 5 O O
al. Reason 5 O O
A Reason 5 O O
systematic Reason 5 O O
review Reason 5 O O
of Reason 5 O O
St. Reason 5 O O
John's Reason 5 O O
wort Reason 5 O O
for Reason 5 O O
major Reason 5 O O
depressive Reason 5 O O
disorder. Reason 5 O O
Syst Reason 5 O O
Rev. Reason 5 O O
2016;5(1):148. Reason 5 O O
11. Reason 5 O O
L, Reason 5 O O
Wort. Reason 5 O O
Clin Reason 5 O O
2004;65(11):1470-1479. Reason 5 O O
12. Reason 5 O O
Stevinson Reason 5 O O
C, Reason 5 O O
Ernst Reason 5 O O
Dir Reason 5 O O
Assoc. Reason 5 O O
2017;18(6):503-508. Reason 5 O O
15. Reason 5 O O
J-J, Reason 5 O O
L-B, Reason 5 O O
Zhang Reason 5 O O
Y, Reason 5 O O
et Reason 5 O O
al. Reason 5 O O
Chronic Reason 5 O O
supplementation Reason 5 O O
of Reason 5 O O
curcumin Reason 5 O O
enhances Reason 5 O O
the Reason 5 O O
efficacy Reason 5 O O
of Reason 5 O O
antidepressants Reason 5 O O
(Crocus Reason 5 O O
L.) Reason 5 O O
major Reason 5 O O
disorder: Reason 5 O O
trials. Reason 5 O O
trial Reason 5 O O
of Reason 5 O O
saffron Reason 5 O O
(Crocus Reason 5 O O
sativus Reason 5 O O
L.) Reason 5 O O
in Reason 5 O O
the Reason 5 O O
treatment Reason 5 O O
of Reason 5 O O
anxiety Reason 5 O O
and Reason 5 O O
J Reason 5 O O
Complement Reason 5 O O
Integr Reason 5 O O
Med. Reason 5 O O
2016;13(2):195-199. Reason 5 O O
18. Reason 5 O O
Firoozeei Reason 5 O O
TS, Reason 5 O O
Feizi Reason 5 O O
A, Reason 5 O O
Rezaeizadeh Reason 5 O O
antidepressant Reason 5 O O
effects Reason 5 O O
of Reason 5 O O
lavender Reason 5 O O
(Lavandula Reason 5 O O
angustifolia Reason 5 O O
Mill.): Reason 5 O O
a Reason 5 O O
systematic Reason 5 O O
review Reason 5 O O
and Reason 5 O O
meta-analysis Reason 5 O O
of Reason 5 O O
Eur Reason 5 O O
Neuropsychopharmacol. Reason 5 O O
2016;26(2):331-340. Reason 5 O O
20. Reason 5 O O
Black Reason 5 O O
N, Reason 5 O O
Stockings Reason 5 O O
E, Reason 5 O O
Campbell Reason 5 O O
G, Reason 5 O O
et Reason 5 O O
al. Reason 5 O O
Cannabinoids Reason 5 O O
for Reason 5 O O
the Reason 5 O O
treatment Reason 5 O O
of Reason 5 O O
mental Reason 5 O O
disorders Reason 5 O O
and Reason 5 O O
symptoms Reason 5 O O
of Reason 5 O O
mental Reason 5 O O
disorders: Reason 5 O O
a Reason 5 O O
systematic Reason 5 O O
review Reason 5 O O
and Reason 5 O O
meta-analysis. Reason 5 O O
Lancet Reason 5 O O
Psychiatry. Reason 5 O O
2019;6(12):995-1010. Reason 5 O O
CN, Reason 5 O O
Brunette Reason 5 O O
Budney Reason 5 O O
AJ. Reason 5 O O
Evidence Reason 5 O O
for Reason 5 O O
use Reason 5 O O
of Reason 5 O O
cannabinoids Reason 5 O O
in Reason 5 O O
mood Reason 5 O O
disorders, Reason 5 O O
anxiety Reason 5 O O
disorders, Reason 5 O O
and Reason 5 O O
PTSD: Reason 5 O O
a Reason 5 O O
systematic Reason 5 O O
et Reason 5 O O
al. Reason 5 O O
Clinician Reason 5 O O
guidelines Reason 5 O O
for Reason 5 O O
the Reason 5 O O
treatment Reason 5 O O
of Reason 5 O O
psychiatric Reason 5 O O
disorders Reason 5 O O
with Reason 5 O O
nutraceuticals Reason 5 O O
and Reason 5 O O
phytoceuticals: Reason 5 O O
The Reason 5 O O
World Reason 5 O O
Federation Reason 5 O O
of Reason 5 O O
Societies Reason 5 O O
of Reason 5 O O
Biological Reason 5 O O
Psychiatry Reason 5 O O
(WFSBP) Reason 5 O O
and Reason 5 O O
Canadian Reason 5 O O
Network Reason 5 O O
for Reason 5 O O
Mood Reason 5 O O
and Reason 5 O O
Anxiety Reason 5 O O
Treatments Reason 5 O O
(CANMAT) Reason 5 O O
